Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL318315

Cn1cc[n+](C)c1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.33
ACHE P22303 6/20 0.33
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
ATM Q13315 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
FDPS P14324 1/20 0.30
GPR3 P46089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4539581 0.86 MAPT (0.36) LMNATP53MAPTTHRBRECQL
Trifluoromethanesulfonamide SCHEMBL28931859 0.85 CA1 (0.41)
Sulfuric Acid SCHEMBL15227677 0.84 MAPT (0.38) LMNATP53MAPTTHRBRECQL
SCHEMBL408787 0.84 MAPT (0.35) LMNATP53MAPTTHRBRECQL
Sulfuric Acid SCHEMBL1293162 0.82 MAPT (0.34) LMNATP53MAPTTHRBRECQL
SCHEMBL16761031 0.82 PTPN11 (0.31)
SCHEMBL29394101 0.82
SCHEMBL409129 0.81 MAPT (0.38) LMNATP53MAPTTHRBRECQL
SCHEMBL29074312 0.79 MAPT (0.37) LMNATP53MAPTTHRBRECQL
SCHEMBL305714 0.79 LMNA (0.33) LMNATP53MAPTTHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288075-A1 ELECTROCHEMICAL FLUIDIC VALVE AND DEVICES CONTAINING THE SAME SWITCHBACK SYSTEMS, INC. (US) 2023-01-19 WO claimed
CN-114437484-B Semi-crystalline ionic gel and preparation method and application thereof 香港中文大学(深圳) 2022-10-18 CN claimed
US-11207640-B2 System and method for adjusting carbon dioxide concentration in indoor atmospheres PALO ALTO RESEARCH CENTER INCORPORATED (US) 2021-12-28 US claimed
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
US-20180257027-A1 SYSTEM AND METHOD FOR ADJUSTING CARBON DIOXIDE CONCENTRATION IN INDOOR ATMOSPHERES PALO ALTO RESEARCH CENTER INCORPORATED (US) 2018-09-13 US claimed
US-8809844-B2 Foldable thin film transistor SAMSUNG ELECTRONICS CO., LTD. (KR) 2014-08-19 US claimed
EP-1658268-B1 MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS NOVARTIS AG (CH) 2014-02-12 EP claimed
US-20130341561-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY, INC. (US) 2013-12-26 US claimed
US-20130140531-A1 FOLDABLE THIN FILM TRANSISTOR INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2013-06-06 US claimed
US-8083945-B2 Fluid storage and purification method and system MATHESON TRI-GAS, INC. (US) 2011-12-27 US claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
US-20070181856-A1 Conductive wet coating composition and thin-film prepared therefrom SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-09 US claimed
US-20070176148-A1 Organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
EP-1712539-A1 METHOD FOR FRIEDEL-CRAFTS ACYLATION IN IONIC LIQUIDS Institut Univ De Ciència I Technologia (ES) 2006-10-18 EP claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP KCNH2 484/4885ACHE 701/4885LMNA 2697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.